BGLC

BIONEXUS GENE LAB CORP

BGLC·090628306·US·Common Stock·Basic Materials - Specialty Chemicals

BGLC (BIONEXUS GENE LAB CORP) is held by 2 institutional investors as of Q1 2026. Largest holders: UBS Group AG ($495), WELLS FARGO & COMPANY/MN ($2). Net institutional sentiment: Bullish.

2
Holders
Avg rating(1 Elite)
$497
Total Value
100% (2)
Fund Consensus
2 buying - 0 selling

No verdict yet — fewer than 2 funds hold BGLC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used